Sarcomas of Soft Tissue and Bone.

The definition of soft tissue and bone sarcomas include a large group of several heterogeneous subtypes of mesenchymal origin that may occur at any age. Among the different sarcomas, rhabdomyosarcoma, synovial sarcoma, Ewing sarcoma and osteosarcoma are aggressive high-grade malignancies that often arise in adolescents and young adults. Managing these malignancies in patients in this age bracket poses various clinical problems, also because different therapeutic approaches are sometimes adopted by pediatric and adult oncologists, even though they are dealing with the same condition. Cooperation between pediatric oncologists and adult medical oncologists is a key step in order to assure the best treatment to these patients, preferably through their inclusion into international clinical trials.

[1]  G. Vassal,et al.  Tumors in Adolescents and Young Adults , 2016 .

[2]  B. Widemann Reply to: Glucarpidase for the Treatment of Methotrexate‐Induced Renal Dysfunction and Delayed Methotrexate Excretion , 2016, Pediatric blood & cancer.

[3]  P. Meyers Glucarpidase for the Treatment of Methotrexate‐Induced Renal Dysfunction and Delayed Methotrexate Excretion , 2016, Pediatric blood & cancer.

[4]  S. Ferrari,et al.  An update on chemotherapy for osteosarcoma , 2015, Expert opinion on pharmacotherapy.

[5]  K. S. Hall,et al.  Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  U. Dirksen,et al.  Ewing Sarcoma: Current Management and Future Approaches Through Collaboration. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  S. Chanock,et al.  Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite , 2015, Nature Genetics.

[8]  P. Hogendoorn,et al.  Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes , 2015, International journal of molecular sciences.

[9]  U. Dirksen,et al.  Local Control in Ewing Sarcoma of the Chest Wall: Results of the EURO-EWING 99 Trial , 2015, Annals of Surgical Oncology.

[10]  M. Sydes,et al.  Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  M. Stevens,et al.  Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005). , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  S. Donaldson,et al.  Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: A report from the Children's Oncology Group , 2015, Cancer.

[13]  R. Randall,et al.  Variability in the reported management of pulmonary metastases in osteosarcoma , 2015, Cancer medicine.

[14]  J. Blay,et al.  Etoposide and carbo‐or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: A large retrospective study , 2015, Pediatric blood & cancer.

[15]  K. S. Hall,et al.  EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment† , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  J. Blay,et al.  Response to chemotherapy is not related to chromosome instability in synovial sarcoma. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  P. Tsagozis,et al.  The Use of Megaprostheses for Reconstruction of Large Skeletal Defects in the Extremities: A Critical Review , 2014, The open orthopaedics journal.

[18]  C. Rodríguez-Galindo,et al.  Internal hemipelvectomy in the management of pelvic Ewing sarcoma - are outcomes better than with radiation therapy? , 2014, Journal of pediatric surgery.

[19]  J. Blay,et al.  1413OZOLEDRONATE DOES NOT REDUCE THE RISK OF TREATMENT FAILURE IN OSTEOSARCOMA: RESULTS OF THE FRENCH MULTICENTRE OS2006 RANDOMISED TRIAL. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  U. Dirksen,et al.  Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  U. Dirksen,et al.  ENCCA WP17-WP7 consensus paper on teenagers and young adults (TYA) with bone sarcomas. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  U. Dirksen,et al.  The value of high‐dose chemotherapy in patients with first relapsed Ewing sarcoma , 2014, Pediatric blood & cancer.

[23]  H. Chuang,et al.  FDG PET/CT of primary bone tumors. , 2014, AJR. American journal of roentgenology.

[24]  James R. Anderson,et al.  Vincristine, dactinomycin, cyclophosphamide (VAC) versus VAC/V plus irinotecan (VI) for intermediate-risk rhabdomyosarcoma (IRRMS): A report from the Children’s Oncology Group Soft Tissue Sarcoma Committee. , 2014 .

[25]  J. Blay,et al.  Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. , 2014, The Lancet. Oncology.

[26]  B. Morland,et al.  A phase II window study of irinotecan (CPT‐11) in high risk ewing sarcoma: A Euro‐E.W.I.N.G. study , 2014, Pediatric blood & cancer.

[27]  S. Lipshultz,et al.  Treatment-related cardiotoxicity in survivors of childhood cancer , 2013, Nature Reviews Clinical Oncology.

[28]  G. Ottaviani,et al.  Sociooccupational and physical outcomes more than 20 years after the diagnosis of osteosarcoma in children and adolescents , 2013, Cancer.

[29]  David M. Thomas,et al.  Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  P. Casali,et al.  Adjuvant Therapy for High-Risk Soft Tissue Sarcoma in the Adult , 2013, Current Treatment Options in Oncology.

[31]  G. Demetri,et al.  Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program study. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[32]  S. Bielack,et al.  Controversies in childhood osteosarcoma. , 2013, Minerva pediatrica.

[33]  Olivier Delattre,et al.  Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  J. Healey,et al.  Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  M. Eriksson,et al.  Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[36]  J. Verweij,et al.  Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. , 2012, The Lancet. Oncology.

[37]  J. Blay,et al.  Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial , 2012, The Lancet.

[38]  A. Ferrari,et al.  The challenge of access to care for soft tissue sarcomas bridging pediatric and adult age: the Italian pediatric oncology view , 2012, Expert review of anticancer therapy.

[39]  A. Ferrari,et al.  Rhabdomyosarcoma in adolescents , 2012, Cancer.

[40]  Andrea Ferrari,et al.  Soft tissue sarcoma across the age spectrum: A population‐based study from the surveillance epidemiology and end results database , 2011, Pediatric blood & cancer.

[41]  H. Gelderblom,et al.  Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand? , 2011, European journal of cancer.

[42]  U. Dirksen,et al.  Risk of recurrence and survival after relapse in patients with Ewing sarcoma , 2011, Pediatric blood & cancer.

[43]  P. Casali,et al.  Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[44]  W. Winkelmann,et al.  The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[45]  L. Mariani,et al.  Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: results of a pooled analysis from United States and European groups. , 2011, European journal of cancer.

[46]  Marc Ladanyi,et al.  Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. , 2010, The New England journal of medicine.

[47]  U. Dirksen,et al.  Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  C. Antonescu,et al.  Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  U. Dirksen,et al.  The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES) , 2010, Cancer.

[50]  S. Bielack,et al.  The role of radiotherapy in oseosarcoma. , 2009, Cancer treatment and research.

[51]  L. Mariani,et al.  The symptom interval in children and adolescents with soft tissue sarcomas , 2009, Cancer.

[52]  Andrea Ferrari,et al.  Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005 , 2009, Cancer.

[53]  A. Ferrari,et al.  Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  S. Bielack,et al.  Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  L. Qin,et al.  A Synovial Sarcoma-Specific Preoperative Nomogram Supports a Survival Benefit to Ifosfamide-Based Chemotherapy and Improves Risk Stratification for Patients , 2008, Clinical Cancer Research.

[56]  U. Dirksen,et al.  Ewing’s Tumors over the Age of 40 – a Retrospective Analysis of 47 Patients Treated According to the International Clinical Trials EICESS 92 and EURO-E.W.I.N.G. 99 , 2008, Oncology Research and Treatment.

[57]  F. Farrokhyar,et al.  A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma , 2008, Cancer.

[58]  J. Eary,et al.  Imaging guidelines for children with Ewing sarcoma and osteosarcoma: A report from the Children's Oncology Group Bone Tumor Committee , 2008, Pediatric blood & cancer.

[59]  S. Bielack,et al.  Osteosarcoma: the same old drugs or more? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  A. Ferrari,et al.  Synovial sarcoma of children and adolescents: the prognostic role of axial sites. , 2008, European journal of cancer.

[61]  James R. Anderson,et al.  Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  Paul A Meyers,et al.  Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  L. Mariani,et al.  Adult-type soft tissue sarcomas in paediatric age: a nomogram-based prognostic comparison with adult sarcoma. , 2007, European journal of cancer.

[64]  Samuel Singer,et al.  Chemotherapy Is Associated With Improved Survival in Adult Patients With Primary Extremity Synovial Sarcoma , 2007, Annals of surgery.

[65]  P. Thall,et al.  Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[66]  S. Ferrari,et al.  Adjuvant and neoadjuvant chemotherapy for Ewing sarcoma family tumors in patients aged between 40 and 60 , 2007, Cancer.

[67]  M Beth McCarville,et al.  Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma , 2007, Pediatric blood & cancer.

[68]  H. Jürgens,et al.  Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors , 2006, Pediatric blood & cancer.

[69]  P. Terrier,et al.  Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  Andrea Ferrari,et al.  Adult-type soft tissue sarcomas in pediatric-age patients: experience at the Istituto Nazionale Tumori in Milan. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  M. Stevens Treatment for childhood rhabdomyosarcoma: the cost of cure. , 2005, The Lancet. Oncology.

[72]  J. Fletcher,et al.  Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[73]  M. Semik,et al.  Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[74]  A. Ferrari,et al.  Vinorelbine and low‐dose cyclophosphamide in the treatment of pediatric sarcomas , 2004, Cancer.

[75]  Rossella Bertulli,et al.  Synovial sarcoma: A retrospective analysis of 271 patients of all ages treated at a single institution , 2004, Cancer.

[76]  James R. Anderson,et al.  Age is an independent prognostic factor in rhabdomyosarcoma: A report from the soft tissue sarcoma committee of the children's oncology group , 2004, Pediatric blood & cancer.

[77]  S. Ferrari,et al.  Therapy and survival after recurrence of Ewing's tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[78]  P. Navarria,et al.  Rhabdomyosarcoma in adults , 2003, Cancer.

[79]  W. Winkelmann,et al.  Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[80]  M. Munsell,et al.  Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[81]  M. Link,et al.  Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[82]  S. Ferrari,et al.  Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[83]  Axel Hoos,et al.  Analysis of the Prognostic Significance of Microscopic Margins in 2,084 Localized Primary Adult Soft Tissue Sarcomas , 2002, Annals of surgery.

[84]  W. Winkelmann,et al.  Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[85]  James R. Anderson,et al.  Rhabdomyosarcoma and Undifferentiated Sarcoma in the First Two Decades of Life: A Selective Review of Intergroup Rhabdomyosarcoma Study Group Experience and Rationale for Intergroup Rhabdomyosarcoma Study V , 2001, Journal of pediatric hematology/oncology.

[86]  A. Craft,et al.  Survival of children with bone sarcoma in Europe since 1978: results from the EUROCARE study. , 2001, European journal of cancer.

[87]  M. Stevens,et al.  Survival of children with soft-tissue sarcoma in Europe since 1978: results from the EUROCARE study. , 2001, European journal of cancer.

[88]  M Bonetti,et al.  Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[89]  C. Antonescu,et al.  Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[90]  W. Winkelmann,et al.  Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[91]  D. Crowther Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data , 1997, The Lancet.

[92]  W. Enneking A system of staging musculoskeletal neoplasms. , 1986, Clinical orthopaedics and related research.

[93]  J. Vilanova WHO Classification of Soft Tissue Tumors , 2017 .

[94]  Silvia Rossi,et al.  Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study. , 2014, The Lancet. Oncology.

[95]  Sydes,et al.  MAPIE vs MAP as postoperative chemotherapy in patients with a poor response to preoperative chemotherapy for newly-diagnosed osteosarcoma: results from EURAMOS-1 (Paper 032) , 2014 .

[96]  C. Fletcher,et al.  WHO classification of tumours of soft tissue and bone , 2013 .

[97]  C. Beauchamp Comparing Children and Adults With Synovial Sarcoma in the Surveillance, Epidemiology, and End Results Program, 1983 to 2005 , 2010 .

[98]  S. Bielack,et al.  Osteosarcoma lung metastases detection and principles of multimodal therapy. , 2009, Cancer treatment and research.

[99]  J. Blay,et al.  Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[100]  C. Beauchamp Second and Subsequent Recurrences of Osteosarcoma: Presentation, Treatment, and Outcomes of 249 Consecutive Cooperative Osteosarcoma Study Group Patients , 2009 .

[101]  P. Thall,et al.  Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[102]  M. Link,et al.  Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[103]  W. Winkelmann,et al.  Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. , 2003, International journal of radiation oncology, biology, physics.

[104]  W. Winkelmann,et al.  Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.